Missing/wrong data?
Log in to edit
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
scientific article published on 14 October 2019
Author/s
author: Faith E Davies, Anna K Waterhouse, Gareth J. Morgan, Martin Kaiser
Work details
Publication date
October 14, 2019
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.